EAACI Congress 2025
BackSAT03 - Takeda – Advancing HAE management: the impact of modern long-term prophylaxis
Objectives
- Explore the continued potential of long-term prophylaxis (LTP) for the management of hereditary angioedema (HAE) based on long-term effectiveness and safety data
- Highlight the patient experience of using LTP through quality of life (QoL) improvements
- Facilitate scientific exchange and clinical experience sharing